Capricor Therapeutics
CAPR
CAPR
30 hedge funds and large institutions have $10.1M invested in Capricor Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 31 → 30 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
30
Holding in Top 10
–
Calls
$739K
Puts
$390K
Top Buyers
| 1 | +$71K | |
| 2 | +$56.9K | |
| 3 | +$31.7K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$21.5K |
Top Sellers
| 1 | -$399K | |
| 2 | -$274K | |
| 3 | -$204K | |
| 4 |
BlackRock
New York
|
-$190K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$113K |